← All companiesVViridian Therapeutics, Inc.DE
VRDN - CIK 0001590750
Viridian Therapeutics, Inc.DE net income by year
Viridian Therapeutics, Inc.DE (VRDN) reported net income of -$342.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
VRDN annual net income
VRDN net income 2013-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$342.60M | -26.9% |
| FY 2024 | -$269.90M | -13.5% |
| FY 2023 | -$237.70M | -83.0% |
| FY 2022 | -$129.90M | -63.6% |
| FY 2021 | -$79.40M | +28.3% |
| FY 2020 | -$110.72M | -164.4% |
| FY 2019 | -$41.87M | -28.0% |
| FY 2018 | -$32.70M | -23.4% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Viridian Therapeutics, Inc.DE make?
Viridian Therapeutics, Inc.DE (VRDN) reported net income of -$342.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Viridian Therapeutics, Inc.DE's net income changed over time?
Between fiscal 2013 and fiscal 2025, Viridian Therapeutics, Inc.DE's net income declined from -$2.16M to -$342.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.